Financials data is unavailable for this security.
View more
Year on year Intellipharmaceutics International Inc grew revenues -- from 0.00 to 65.73k while net income improved from a loss of 5.15m to a smaller loss of 2.89m.
| Gross margin | -88.96% |
|---|---|
| Net profit margin | -350.72% |
| Operating margin | -285.07% |
| Return on assets | -211.39% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2022, cash reserves at Intellipharmaceutics International Inc fell by 688.23k. However, Cash Flow from Investing totalled 500.00k, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 1.39m for operations while cash generated from financing totalled 200.00k.
| Cash flow per share | -0.123 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.528 |
|---|---|
| Tangible book value per share | -0.528 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.0597 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
